Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the complete record of transactions filed by Gray Peter, Director. Director active across 1 company, notably Jazz Pharmaceuticals plc. Aggregated, 5 disclosures have been published. Breakdown: 0 buy · 1 sell. Total volume traded: €177k. History available since 29 July 2021. The latest transaction was filed on 11 August 2023 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 of 5 declarations
Peter Gray is a Board Member at Jazz Pharmaceuticals plc. He brings his expertise in governance and corporate strategy, actively participating in discussions and decisions within the board.